PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
4.970
-0.130 (-2.55%)
At close: Dec 20, 2024, 4:00 PM
4.870
-0.100 (-2.01%)
After-hours: Dec 20, 2024, 5:39 PM EST

Company Description

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.

The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.

It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.

The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc.
PetMed Express logo
Country United States
Founded 1996
Industry Pharmaceutical Retailers
Sector Healthcare
Employees 287
CEO Sandra Campos

Contact Details

Address:
420 South Congress Avenue
Delray Beach, Florida 33445
United States
Phone 561 526 4444
Website 1800petmeds.com

Stock Details

Ticker Symbol PETS
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001040130
CUSIP Number 716382106
ISIN Number US7163821066
Employer ID 65-0680967
SIC Code 5912

Key Executives

Name Position
Sandra Y. Campos President, Chief Executive Officer and Director
Christine Chambers Treasurer and Secretary
Robyn DElia Chief Financial Officer
Caroline Conegliano Chief Operating Officer
Doug Krulik Chief Accounting Officer
Mark Moseley Chief Technology and Information Officer
Carla Dodds Chief Marketing Officer
Jacqueline Smith Vice President of People
Umesh Sripad Chief Digital and Technology Officer
Wendy Zalai Corporate Controller and Corporate Secretary

Latest SEC Filings

Date Type Title
Dec 18, 2024 8-K/A [Amend] Current report
Dec 3, 2024 8-K Current Report
Dec 3, 2024 8-A12B Registration of securities
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 10-Q Quarterly Report
Nov 6, 2024 8-K Current Report
Oct 10, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Sep 27, 2024 8-K Current Report
Sep 27, 2024 S-8 Securities to be offered to employees in employee benefit plans
Sep 12, 2024 8-K Current Report